Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 9.

Journal Article

Colombo, Carla, Burgel, Pierre-Regis, Gartner, Silvia, van Koningsbruggen-Rietschel, Silke, Naehrlich, Lutz, Sermet-Gaudelus, Isabelle and Southern, Kevin W. (2020). Impact of COVID-19 on people with cystic fibrosis. Lancet Resp. Med., 8 (5). S. E35 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600

Davies, Jane C., Van de Steen, Olivier, van Koningsbruggen-Rietschel, Silke, Drevinek, Pavel, Derichs, Nico, McKone, Edward F., Kanters, Desiree, Allamassey, Lisa, Namour, Florence, de Kock, Herman and Conrath, Katja (2019). GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1). J. Cyst. Fibros, 18 (5). S. 693 - 700. AMSTERDAM: ELSEVIER. ISSN 1873-5010

Dinger, Katharina, Kasper, Philipp, Hucklenbruch-Rother, Eva, Vohlen, Christina, Jobst, Eva, Janoschek, Ruth, Bae-Gartz, Inga, van Koningsbruggen-Rietschel, Silke, Plank, Christian, Doetsch, Joerg and Alcazar, Miguel Angel Alejandre (2016). Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice. Sci Rep, 6. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Thangaratnarajah, Chansutha, Dinger, Katharina, Vohlen, Christina, Klaudt, Christian, Nawabi, Jawed, Garcia, Eva Lopez, Kwapiszewska, Grazyna, Dobner, Julia, Nuesken, Kai D., van Koningsbruggen-Rietschel, Silke, von Hoersten, Stephan, Doetsch, Joerg and Alcazar, Miguel A. Alejandre (2017). Novel role of NPY in neuroimmune interaction and lung growth after intrauterine growth restriction. Am. J. Physiol.-Lung Cell. Mol. Physiol., 313 (3). S. L491 - 16. BETHESDA: AMER PHYSIOLOGICAL SOC. ISSN 1522-1504

Thomassen, Jan C., Mueller, Matthias I., Alcazar, Miguel A. Alejandre, Rietschel, Ernst and van Koningsbruggen-Rietschel, Silke (2018). Effect of Lumacaftor/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients. J. Cyst. Fibros, 17 (2). S. 271 - 276. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-5010

van Koningsbruggen-Rietschel, Silke (2018). Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug Res., 68. S. S21 - 3. STUTTGART: GEORG THIEME VERLAG KG. ISSN 2194-9387

van Koningsbruggen-Rietschel, Silke (2019). Novel treatment modalities for cystic fibrosis. Pneumologe, 16 (2). S. 88 - 98. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1613-6055

van Koningsbruggen-Rietschel, Silke, Conrath, Katja, Fischer, Rainald, Sutharsan, Sivagurunathan, Kempa, Axel, Gleiber, Wolfgang, Schwarz, Carsten, Hector, Andreas, Van Osselaer, Nancy, Pano, Arian, Corveleyn, Sam, Bwirire, Dieudonne, Santermans, Eva, Muller, Karine, Bellaire, Susan and Van de Steen, Olivier (2020). GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN). J. Cyst. Fibros, 19 (2). S. 292 - 299. AMSTERDAM: ELSEVIER. ISSN 1873-5010

van Koningsbruggen-Rietschel, Silke, Dunlevy, Fiona, Bulteel, Veerle, Downey, Damian G. and Dupont, Lieven (2020). SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network. Eur. Resp. J., 56 (3). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

This list was generated on Sun Mar 7 05:05:47 2021 CET.